|
|
|
Cambridge Healthtech Institute, San Diego, California
January 11-12, 2005
Considering the risks and costs of new drug development, it is critical to eliminate high-risk leads as early as possible. Computational (in silico) screening has become a valuable tool to predict the interaction of a compound with the biological system. Absorption, distribution, metabolism, excretion and toxicology are all important issues to consider when developing accurate and predictive models. Conveniently co-located, these conferences review techniques and strategies for developing faster and yet more accurate models to predict the ADME and Toxicology of new lead compounds.
|
|
|
|
|
|
Organized by:
|
|
CHI |
|
Invited Speakers:
|
|
For more information, visit: www.healthtech.com/2005/tox/index.asp
|
|
|
|
|
|
Deadline for Abstracts:
|
|
.
|
|
|
|
|
|
Registration:
|
|
For more information, visit: www.healthtech.com/2005/tox/index.asp
|
|
E-mail:
|
|
lcardinale@healthtech.com
|
|
|
|
|
|
|
|